Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 mg/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 mg/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 mg/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 mg/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [ACEL-IMUNE]
RxNorm 1300403
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1300403 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 mg/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 mg/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 mg/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 mg/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [ACEL-IMUNE].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.